(Reuters) – Guardian Pharmacy’s shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million. (Reporting by Jaiveer Singh Shekhawat in Bengaluru; Editing by Shreya Biswas)
Comments